Fda

Feb 12, 2016 at 21:18 | Source: PTI
The significant violations included the company's failure "to maintain floors, walls, and ceilings of smooth, hard surfaces that are easily cleanable in aseptic processing areas".
Feb 02, 2016 at 09:57 | Source: Moneycontrol.com
The company's subsidiary has received final approval for Imatinib Mesylate from Food and Drug Administration (FDA) in December 2015.
Feb 01, 2016 at 08:19 | Source: CNBC-TV18
US regulator conducted inspections in oral solid facilities of Aurobindio - Unit 3 and Unit 7. While the Unit 3 was cleared with no form 483 for observations, Unit 7 saw few observations from the regulator.
Jan 28, 2016 at 11:51 | Source: CNBC-TV18
Speaking to CNBC-TV18, Mahantesh Sabarad, Deputy-VP Research at SBICap Securities says he is positive on sectors like banks, automobile, auto ancillaries and cement.
Jan 21, 2016 at 12:39 | Source: PTI
"Glenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (US FDA) for Potassium Chloride extended release capsules USP, 10mEq, of Actavis Laboratories FL, Inc," the company said in a BSE filing.
Jan 18, 2016 at 13:04 | Source: CNBC-TV18
Abhishek Sharma, Pharma Analyst at IIFL recommends buying Glenmark Pharma and likes Lupin and Dr Reddy's Labs.
Jan 18, 2016 at 12:34 | Source: CNBC-TV18
Sharma, however, believes that despite the issues getting compounded by the day, most of the companies have enough capabilities to resolve them within the next 12-15 months.
Jan 18, 2016 at 11:14 | Source: CNBC-TV18
Habil Khorakiwala, Founder, Chairman and Group CEO, Wockhardt says all facilities were inspected in the past six months and none of the US FDA observations are critical in nature, while adding that all these observations will be resolved in next 2-3 months
Jan 16, 2016 at 11:25 | Source: Moneycontrol.com
Wockhardt has informed that
Jan 08, 2016 at 14:40 | Source: Moneycontrol.com
Lupin has received final approval for its Kaitlib Fe Tablets from USFDA to market a generic version of Warner Chilcott's Generess Fe Chewable Tablets.
Messages on Fda »

BSE/NSE Announcer

Platinum Member

11656 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

11656 Followers

Glenmark  

the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

11656 Followers

Shasun Pharma  

Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 08, 2014, titled "Sucessful completion of US FDA and Mexican COFEPRIS inspection".

11.41 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

11656 Followers

Shasun Pharma  

Shasun Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014, titled "Successful completion of US FDA and Mexican COFEPRIS inspection"

11.30 AM Jul 8th 2014

hemal85

Silver Member

13 Followers

ITC  

how FDA (food & drug authority) is related with Mr. Modi?? & if u mean FDI....how will that make any difference to HUL or ITC??? kuchh bhi....

6.55 PM Jul 7th 2014

teeyen

Silver Member

7 Followers

Natco Pharma  

Natco is an excellent stock with good prospects. However think of following before buying now. 1)Teva has filed a citizen petition before FDA which may delay copaxone generic approval by about 5-6 months 2) Teva has filed a petition in delhi high court for stopping production and export

6.38 PM Jul 7th 2014

AlphaView

Gold Member

190 Followers

Granules India  

talking this even after discounting for risks such as FDA approvals et al.

6.13 PM Jul 7th 2014

niftynewbie

Platinum Member

449 Followers

Ranbaxy Labs  

Spoiler could be sunpharma`s plants getting red-flagged by FDA ;)

5.10 PM Jul 7th 2014

Sharon Bio Medicine  

Profit to fo up 3 fold! US FDA approval to come next qrtr!

3.22 PM Jul 7th 2014

shivamparik
h

Platinum Member

98 Followers

ITC  

HUL doesnt deal in Cigarettes and FDA will be welcome by Mr. Modi. ITC may get benefits of Tourism ... HUL still wins out with a higher chance of UL bidding for complete or more control through buy out of shares. ITC will have issues with Govt. regulations in my opinion.

1.18 PM Jul 7th 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.